z-logo
open-access-imgOpen Access
<p>Expression and significance of LncRNA MNX1-AS1 in non-small cell lung cancer</p>
Author(s) -
Gaofeng Liu,
Xiaofeng Guo,
Yong Zhang,
Yan Liu,
Dandan Li,
Guangyao Tang,
Sujuan Cui
Publication year - 2019
Publication title -
oncotargets and therapy
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.054
H-Index - 60
ISSN - 1178-6930
DOI - 10.2147/ott.s198014
Subject(s) - gene knockdown , cancer research , lung cancer , cell growth , apoptosis , a549 cell , oncology , biology , medicine , cell culture , biochemistry , genetics
Objective: To investigate the expression of LncRNA MNX1-AS1 in NSCLC and its effect on NSCLC cell lines. Methods: In this experiment, the expression of LncRNA MNX1-AS1 was detected by qRT-PCR in 116 NSCLC samples, and the correlation between MNX1-AS1 and NSCLC patients was further analyzed by chi-square test. The prognostic value of MNX1-AS1 was assessed by Kaplan-Meier survival curve. The expression of MNX1-AS1 in NSCLC cell line A549 was knocked down, and the effects of MNX1-AS1 on proliferation, apoptosis, migration and invasion of NSCLC cells were evaluated. Results: Compared with normal lung tissue, the expression of MNX1-AS1 was significantly increased in lung cancer tissues ( p <0.05). The expression level of MNX1-AS1 in NSCLC cell line A549 was significantly higher than that in human normal lung epithelial cell line Beas-2B ( p <0.05). MNX1-AS1 expression was significantly associated with TNM stage and lymph node metastasis ( p <0.05). Kaplan-Meier survival curve analysis showed that high expression of MNX1-AS1 was associated with a poor prognosis in NSCLC. In addition, knockdown of MNX1-AS1 inhibited proliferation, migration and invasion of the NSCLC cell line A549 and promoted apoptosis. Conclusion: The up-regulation of LncRNA MNX1-AS1 is associated with the progression and prognosis of NSCLC. Knockdown of LncRNA MNX1-AS1 inhibits proliferation, migration and invasion of NSCLC cells and promotes apoptosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here